184 related articles for article (PubMed ID: 37322557)
1. B cell subsets in adult-onset Still's disease: potential candidates for disease pathogenesis and immunophenotyping.
Fang X; Ye H; Xie Y; Wei C; Liu S; Yao H; Li Z; Jia Y; Hu F
Arthritis Res Ther; 2023 Jun; 25(1):104. PubMed ID: 37322557
[TBL] [Abstract][Full Text] [Related]
2. The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study.
Liu X; Guo R; Meng X; Fang J; Lu L
Front Immunol; 2020; 11():560744. PubMed ID: 33329521
[TBL] [Abstract][Full Text] [Related]
3. Deep Immunophenotyping of Circulating T and B Cells in Relapsing Adult-Onset Still's Disease.
Myachikova V; Kudryavtsev I; Rubinstein A; Aquino A; Isakov D; Golovkin A; Maslyanskiy A
Curr Issues Mol Biol; 2024 Feb; 46(2):1177-1191. PubMed ID: 38392193
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.
Jia J; Wang M; Ma Y; Meng J; Zhu D; Chen X; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Zhou Z; Wang F; Chen L; Yi D; Xiao Y; Yang C; Teng J; Hu Q
BMC Med; 2023 Dec; 21(1):507. PubMed ID: 38124139
[TBL] [Abstract][Full Text] [Related]
5. Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease.
Jung JY; Choi B; Sayeed HM; Suh CH; Kim YW; Kim HA; Sohn S
Int J Immunopathol Pharmacol; 2018; 32():2058738418791284. PubMed ID: 30052100
[TBL] [Abstract][Full Text] [Related]
6. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
Zhou X; Li Y; Wang Q
Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
[TBL] [Abstract][Full Text] [Related]
8. AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis.
Guo R; Liu X; Li Y; Meng X; Li R; Chen X; Lu L
Rheumatology (Oxford); 2023 Apr; 62(4):1636-1644. PubMed ID: 35972374
[TBL] [Abstract][Full Text] [Related]
9. Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still's Disease: A Machine Learning Study.
Jia J; Wang M; Ma Y; Teng J; Shi H; Liu H; Sun Y; Su Y; Meng J; Chi H; Chen X; Cheng X; Ye J; Liu T; Wang Z; Wan L; Zhou Z; Wang F; Yang C; Hu Q
Front Immunol; 2020; 11():563335. PubMed ID: 33240258
[TBL] [Abstract][Full Text] [Related]
10. The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.
Chi H; Hong X; Dai N; Chen L; Zhang H; Liu H; Cheng X; Ye J; Shi H; Hu Q; Meng J; Zhou Z; Jia J; Liu T; Wang F; Wang M; Ma Y; Chen X; You Y; Zhu D; Tang Z; Yang C; Teng J; Su Y; Sun Y
Rheumatology (Oxford); 2023 Sep; ():. PubMed ID: 37756690
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
Liu Y; Xia C; Chen J; Fan C; He J
Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.
Ruscitti P; Cipriani P; Masedu F; Iacono D; Ciccia F; Liakouli V; Guggino G; Carubbi F; Berardicurti O; Di Benedetto P; Valenti M; Triolo G; Valentini G; Giacomelli R
BMC Med; 2016 Dec; 14(1):194. PubMed ID: 27903264
[TBL] [Abstract][Full Text] [Related]
15. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
16. Association of the Leukocyte Immunoglobulin-like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult-Onset Still's Disease.
Wang M; Liu M; Jia J; Shi H; Teng J; Liu H; Sun Y; Cheng X; Ye J; Su Y; Chi H; Liu T; Wang Z; Wan L; Meng J; Ma Y; Yang C; Hu Q
Arthritis Rheumatol; 2021 Jun; 73(6):1033-1043. PubMed ID: 33381895
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.
Li H; Abramova I; Chesoni S; Yao Q
Clin Rheumatol; 2018 Aug; 37(8):2021-2026. PubMed ID: 29909561
[TBL] [Abstract][Full Text] [Related]
18. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
[TBL] [Abstract][Full Text] [Related]
19. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
20. Catastrophic adult-onset Still's disease as a distinct life-threatening clinical subset: case-control study with dimension reduction analysis.
Wahbi A; Tessoulin B; Bretonnière C; Boileau J; Carpentier D; Decaux O; Fardet L; Geri G; Godmer P; Goujard C; Maisonneuve H; Mari A; Pouchot J; Ziza JM; Georgin-Lavialle S; Hamidou M; Néel A
Arthritis Res Ther; 2021 Oct; 23(1):256. PubMed ID: 34635157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
